Equity (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of warrants outstanding

	Shares of Common Stock Issuable from Warrants Outstanding as of			Weighted
		September 30,	December 31,		Average
Description		2022	2021		Exercise Price	Expiration
Series F		-	7,246	$	3.45	February 23, 2022
Series G		-	460,250	$	2.68	July 21, 2022
Series H		910,000	910,000	$	2.75	October 16, 2022
Series I		10,335,000	10,335,000	$	2.00	November 26, 2025
Total		11,245,000	11,712,496

Schedule of stock option activity

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2021		3,139,999			2.17
Granted		-			-
Forfeited		(115,000	)		2.23
Outstanding at September 30, 2022		3,024,999			2.17		3.84		-
Vested and exercisable at September 30, 2022		2,674,999			2.03		3.79 years		-

Schedule of consolidated statement of operations

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Research and development	$	289,997	$	224,000	$	724,997	$	731,438
General and administrative		-		44,000		5,500		(1,138,601	)
Total	$	289,997	$	268,000	$	730,497	$	(407,163	)